Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D. 1990

M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
Section on Analytical Biochemistry, NIMH, Bethesda, MD 20892.

Sustained increases in CSF concentrations of the excitotoxin quinolinic acid (QUIN) occur in patients with AIDS and have been implicated in the pathogenesis of the AIDS dementia complex. Macaques in captivity may also develop immunodeficiency syndromes caused by retrovirus infection, including simian retrovirus type-D. In the present study, CSF QUIN concentrations were moderately increased in retrovirus type-D-positive/antibody-negative macaques (163.8 +/- 35.1 nmol/l; P less than 0.0001, n = 21) but not virus-negative/antibody-positive macaques (27.4 +/- 9.4 nmol/l, n = 8) compared to uninfected control macaques (23.0 +/- 1.6 nmol/l; n = 22). CSF QUIN concentrations in virus-positive/antibody-negative macaques tended to remain elevated over a 4-20 month period. Post-mortem studies of 9 virus-positive/antibody-negative macaques and 6 virus-negative/antibody-positive macaques revealed inflammatory responses in the brains of 6 of 9 virus-positive/antibody negative macaques, including lymphocytic infiltrates of the choroid plexus in 3 macaques, glial nodules in 3 macaques and perivascular infiltrates in 1 macaque. These lesions were not extensive and no evidence of brain atrophy was observed. No lesions were observed in the 6 antibody-positive/virus-negative macaques. Small increases in plasma L-kynurenine in virus-positive/antibody-negative macaques are consistent with activation of indoleamine-2,3-dioxygenase, the first enzyme in the kynurenine pathway. We conclude that sustained moderate increases in CSF QUIN occur in viremic simian retrovirus type-D macaques. The increases in CSF QUIN may reflect inflammatory responses within the brain or synthesis of QUIN precursors in systemic tissues, their entry into brain and subsequent conversion to QUIN. The neuropathologic significance of these increases in CSF QUIN remains to be determined.

UI MeSH Term Description Entries
D007736 Kynurenic Acid A broad-spectrum excitatory amino acid antagonist used as a research tool. Kynurenate,Acid, Kynurenic
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D011805 Quinolinic Acids Dicarboxylic acids with a PYRIDINE backbone. Quinolinic Acids are downstream products of the KYNURENINE pathway which metabolize amino acid TRYPTOPHAN. Acids, Quinolinic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan
D015301 Retroviruses, Simian Classes of retroviruses for which monkeys or apes are hosts. Those isolated from the West African green monkey and the Asian rhesus macaque monkey are of particular interest because of their similarities to viruses causing cancer and acquired immunodeficiency syndrome (AIDS) in humans. Chimpanzee Retroviruses,Monkey Retroviruses,Simian Retroviruses,Chimpanzee Retrovirus,Monkey Retrovirus,Retrovirus, Chimpanzee,Retrovirus, Monkey,Retrovirus, Simian,Retroviruses, Chimpanzee,Retroviruses, Monkey,Simian Retrovirus
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D017378 Quinolinic Acid A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. Quinolinate,Quinolinic Acid, Copper(2+) Salt,Quinolinic Acid, Disodium Salt,Quinolinic Acid, Strontium Salt

Related Publications

M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
May 1991, AIDS (London, England),
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
January 2005, Veterinary pathology,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
January 1993, Journal of medical primatology,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
January 2011, Journal of the American Association for Laboratory Animal Science : JAALAS,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
June 1990, Annals of neurology,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
December 2014, Journal of medical primatology,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
January 1986, American journal of primatology,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
November 2011, Veterinary pathology,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
June 2004, Comparative medicine,
M P Heyes, and M Gravell, and W T London, and M Eckhaus, and J H Vickers, and J A Yergey, and M April, and D Blackmore, and S P Markey
January 1994, AIDS research and human retroviruses,
Copied contents to your clipboard!